-$0.30 EPS Expected for Intec Pharma (NTEC) This Quarter
Wall Street brokerages expect that Intec Pharma will post earnings of per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Intec Pharma's earnings.
Start the conversation, or Read more at AmericanBankingNews.com.
Copyright © 2018 Topix LLC